These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2899641)

  • 1. "The influence of conformational factors on the metabolic conjugation of aryloxyacetates"--a comment.
    Kennard CH; Smith G
    J Pharm Pharmacol; 1988 May; 40(5):380. PubMed ID: 2899641
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of conformational factors on the metabolic conjugation of aryloxyacetates.
    van de Waterbeemd H; Testa B; Caldwell J
    J Pharm Pharmacol; 1986 Jan; 38(1):14-8. PubMed ID: 2869120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.
    Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR
    Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of hypolipidemic and antiplatelet actions from adverse myotonic effects of clofibric acid related enantiomers.
    Feller DR; Kamanna VS; Newman HA; Romstedt KJ; Witiak DT; Bettoni G; Bryant SH; Conte-Camerino D; Loiodice F; Tortorella V
    J Med Chem; 1987 Aug; 30(8):1265-7. PubMed ID: 2441050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues.
    Bettoni G; Loiodice F; Tortorella V; Conte-Camerino D; Mambrini M; Ferrannini E; Bryant SH
    J Med Chem; 1987 Aug; 30(8):1267-70. PubMed ID: 2441051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 4-chloro-2-methylphenol as a soil degradation product of ring-labelled [14C]mecoprop.
    Smith AE
    Bull Environ Contam Toxicol; 1985 May; 34(5):656-60. PubMed ID: 4005444
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucuronic acid conjugates of clofibrate: four isomeric structures.
    Hignite CE; Tschanz C; Lemons S; Wiese H; Azarnoff DL; Huffman DH
    Life Sci; 1981 May; 28(18):2077-81. PubMed ID: 7242269
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology and mechanism of action of etofibrate].
    Schatton W
    Med Welt; 1982 Sep; 33(38):1310-4. PubMed ID: 6752630
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution and elimination of 2-methyl-4-chlorophenoxyacetic acid (MCPA) in male rats.
    Elo H
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):58-64. PubMed ID: 988972
    [No Abstract]   [Full Text] [Related]  

  • 10. Species variation in the taurine conjugation of clofibric acid [proceedings].
    Caldwell J; Emudianughe TS; Smith RL
    Br J Pharmacol; 1979 Jul; 66(3):421P-422P. PubMed ID: 526711
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of bezafibrate after single and multiple doses in the presence of renal failure.
    Abshagen U; Kösters W; Kaufmann B; Lang PD
    Klin Wochenschr; 1980 Sep; 58(17):889-96. PubMed ID: 7442088
    [No Abstract]   [Full Text] [Related]  

  • 12. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man.
    Emudianughe TS; Caldwell J; Sinclair KA; Smith RL
    Drug Metab Dispos; 1983; 11(2):97-102. PubMed ID: 6133730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of clofibric acid in blood after the administration of delayed-release form of etofibrate.
    Vazquez Lopez F; Armijo Castro F; Pire Solis I; Gutierrez Fuentes JA
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):31-5. PubMed ID: 3557726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of structure and a secondary carbon source on the microbial degradation of chlorophenoxy acids.
    Evangelista S; Cooper DG; Yargeau V
    Chemosphere; 2010 May; 79(11):1084-8. PubMed ID: 20392474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial increase in the levels of chlorophenoxyacetic acids in the CNS of rats as a result of severe intoxication.
    Elo H; Ylitalo P
    Acta Pharmacol Toxicol (Copenh); 1977 Sep; 41(3):280-4. PubMed ID: 578657
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic approach of plafibride in rat.
    Zapatero D; Vilageliu J; Torres A; Ribalta JM; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1800-4. PubMed ID: 7198457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of plafibride in healthy volunteers.
    Santaniello E; Conti F; Vilageliu J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1850-2. PubMed ID: 7198464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs.
    Garrett ER; Altmayer P
    J Pharm Sci; 1985 Mar; 74(3):295-9. PubMed ID: 4009437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stability of antilipidemic etofibrate and its metabolites towards gastrointestinal and blood hydrolases (author's transl)].
    Oelschläger H; Rothley D; Ewert M; Nachev P
    Arzneimittelforschung; 1980; 30(6):984-8. PubMed ID: 7191278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of 2,4-D and MCPA in soils of low pH.
    Torstensson NT
    Environ Qual Saf Suppl; 1975; 3():262-5. PubMed ID: 5271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.